Guergana Kirilova Savova, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Language Processing | 58 | 2024 | 1041 | 8.340 |
Why?
|
| Electronic Health Records | 45 | 2023 | 4468 | 3.520 |
Why?
|
| Information Storage and Retrieval | 17 | 2023 | 824 | 2.460 |
Why?
|
| Data Mining | 14 | 2019 | 537 | 1.890 |
Why?
|
| Aneurysm, Ruptured | 14 | 2021 | 452 | 1.660 |
Why?
|
| Intracranial Aneurysm | 17 | 2021 | 1197 | 1.510 |
Why?
|
| Vocabulary, Controlled | 9 | 2014 | 170 | 1.240 |
Why?
|
| Semantics | 11 | 2019 | 584 | 1.050 |
Why?
|
| Narration | 6 | 2013 | 212 | 0.980 |
Why?
|
| Linguistics | 4 | 2013 | 97 | 0.960 |
Why?
|
| Algorithms | 29 | 2020 | 13881 | 0.880 |
Why?
|
| Computer Systems | 3 | 2017 | 483 | 0.700 |
Why?
|
| Disease | 2 | 2015 | 680 | 0.680 |
Why?
|
| Medical Records Systems, Computerized | 6 | 2013 | 1205 | 0.640 |
Why?
|
| Classification | 2 | 2009 | 129 | 0.640 |
Why?
|
| APACHE | 1 | 2017 | 277 | 0.570 |
Why?
|
| Software | 6 | 2023 | 4443 | 0.520 |
Why?
|
| Artificial Intelligence | 9 | 2023 | 2214 | 0.510 |
Why?
|
| Radiation Oncology | 1 | 2021 | 555 | 0.500 |
Why?
|
| Neoplasms | 10 | 2023 | 21683 | 0.470 |
Why?
|
| Medical Informatics | 5 | 2017 | 745 | 0.470 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2019 | 1018 | 0.460 |
Why?
|
| Anatomy | 1 | 2013 | 112 | 0.410 |
Why?
|
| Anterior Cerebral Artery | 2 | 2021 | 48 | 0.380 |
Why?
|
| Pattern Recognition, Automated | 3 | 2013 | 1005 | 0.380 |
Why?
|
| Colitis, Ulcerative | 7 | 2019 | 1912 | 0.380 |
Why?
|
| Search Engine | 1 | 2011 | 144 | 0.360 |
Why?
|
| Crohn Disease | 7 | 2019 | 2303 | 0.360 |
Why?
|
| Basilar Artery | 2 | 2021 | 200 | 0.360 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2015 | 3712 | 0.330 |
Why?
|
| Methotrexate | 1 | 2014 | 1727 | 0.310 |
Why?
|
| Medical Oncology | 1 | 2019 | 2265 | 0.300 |
Why?
|
| Phenotype | 10 | 2019 | 16365 | 0.290 |
Why?
|
| Language | 2 | 2024 | 1471 | 0.290 |
Why?
|
| Pharmacogenetics | 1 | 2011 | 675 | 0.280 |
Why?
|
| Circle of Willis | 3 | 2021 | 68 | 0.280 |
Why?
|
| Humans | 95 | 2023 | 744343 | 0.270 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 9239 | 0.260 |
Why?
|
| Smoking | 3 | 2017 | 8987 | 0.250 |
Why?
|
| Cerebral Angiography | 5 | 2021 | 1285 | 0.240 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 1405 | 0.240 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2011 | 1524 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 1 | 2011 | 1071 | 0.210 |
Why?
|
| Esophagitis | 1 | 2023 | 152 | 0.210 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4149 | 0.200 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 20822 | 0.200 |
Why?
|
| Systematized Nomenclature of Medicine | 2 | 2014 | 36 | 0.200 |
Why?
|
| Time | 2 | 2015 | 542 | 0.190 |
Why?
|
| Medical Informatics Applications | 2 | 2013 | 186 | 0.190 |
Why?
|
| Reference Standards | 3 | 2014 | 1025 | 0.190 |
Why?
|
| Middle Cerebral Artery | 1 | 2021 | 264 | 0.180 |
Why?
|
| Peripheral Arterial Disease | 1 | 2010 | 1188 | 0.180 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 15540 | 0.170 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 92 | 0.170 |
Why?
|
| Disabled Persons | 2 | 2007 | 1212 | 0.160 |
Why?
|
| Health Facilities | 1 | 2023 | 573 | 0.160 |
Why?
|
| Ecosystem | 1 | 2021 | 474 | 0.150 |
Why?
|
| Disease Progression | 2 | 2013 | 13284 | 0.150 |
Why?
|
| Heroin Dependence | 1 | 2017 | 175 | 0.140 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 367 | 0.140 |
Why?
|
| Clinical Coding | 2 | 2015 | 171 | 0.140 |
Why?
|
| Unified Medical Language System | 2 | 2014 | 86 | 0.140 |
Why?
|
| Female | 39 | 2023 | 380194 | 0.140 |
Why?
|
| Nursing Care | 2 | 2007 | 74 | 0.140 |
Why?
|
| Knowledge Bases | 1 | 2016 | 85 | 0.140 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 2418 | 0.130 |
Why?
|
| Aneurysm | 1 | 2018 | 339 | 0.130 |
Why?
|
| Terminology as Topic | 5 | 2013 | 1547 | 0.130 |
Why?
|
| Prostate | 1 | 2023 | 1774 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 2703 | 0.130 |
Why?
|
| Magnesium | 1 | 2018 | 813 | 0.130 |
Why?
|
| Reproducibility of Results | 6 | 2017 | 19905 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4420 | 0.120 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 494 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.120 |
Why?
|
| Medical Informatics Computing | 1 | 2013 | 25 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2018 | 604 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2023 | 1583 | 0.110 |
Why?
|
| Ownership | 1 | 2015 | 332 | 0.110 |
Why?
|
| Male | 33 | 2023 | 350118 | 0.110 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3589 | 0.110 |
Why?
|
| Case-Control Studies | 9 | 2021 | 21746 | 0.100 |
Why?
|
| Logistic Models | 8 | 2019 | 13408 | 0.100 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2690 | 0.100 |
Why?
|
| Confidentiality | 2 | 2013 | 612 | 0.100 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 1814 | 0.100 |
Why?
|
| Nursing Records | 2 | 2008 | 28 | 0.100 |
Why?
|
| Medical Records | 5 | 2020 | 1413 | 0.100 |
Why?
|
| Documentation | 2 | 2008 | 871 | 0.100 |
Why?
|
| Health | 2 | 2005 | 394 | 0.090 |
Why?
|
| Iron | 1 | 2019 | 1774 | 0.090 |
Why?
|
| Registries | 2 | 2023 | 8089 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2011 | 1164 | 0.090 |
Why?
|
| Warfarin | 1 | 2018 | 1496 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2013 | 3748 | 0.090 |
Why?
|
| Psychology | 1 | 2011 | 356 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2716 | 0.090 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2021 | 341 | 0.090 |
Why?
|
| Methods | 1 | 2009 | 1129 | 0.090 |
Why?
|
| Middle Aged | 22 | 2021 | 213383 | 0.090 |
Why?
|
| Information Systems | 1 | 2011 | 410 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1537 | 0.080 |
Why?
|
| Computational Biology | 2 | 2016 | 3521 | 0.080 |
Why?
|
| Radiology Information Systems | 2 | 2013 | 523 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.080 |
Why?
|
| Aged | 17 | 2021 | 163280 | 0.080 |
Why?
|
| Nursing Diagnosis | 2 | 2008 | 18 | 0.080 |
Why?
|
| Aromatase Inhibitors | 1 | 2011 | 491 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 14722 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2010 | 550 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2019 | 2425 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 981 | 0.070 |
Why?
|
| Risk Factors | 13 | 2021 | 72290 | 0.070 |
Why?
|
| Information Services | 1 | 2008 | 244 | 0.070 |
Why?
|
| Aspirin | 1 | 2018 | 3282 | 0.070 |
Why?
|
| Child | 5 | 2023 | 77709 | 0.070 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2017 | 2071 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 2872 | 0.060 |
Why?
|
| Age Factors | 3 | 2021 | 18370 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2020 | 40561 | 0.060 |
Why?
|
| Calcium | 1 | 2018 | 5756 | 0.060 |
Why?
|
| Multivariate Analysis | 4 | 2020 | 12245 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2018 | 3114 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 3966 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2012 | 1099 | 0.060 |
Why?
|
| Adult | 17 | 2021 | 214055 | 0.060 |
Why?
|
| Rheumatic Diseases | 1 | 2010 | 592 | 0.060 |
Why?
|
| Minnesota | 3 | 2010 | 344 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1343 | 0.060 |
Why?
|
| Antirheumatic Agents | 1 | 2013 | 1339 | 0.060 |
Why?
|
| Nursing | 1 | 2003 | 40 | 0.060 |
Why?
|
| Hospitalization | 2 | 2013 | 10262 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2018 | 4599 | 0.060 |
Why?
|
| Biomedical Research | 4 | 2013 | 3309 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2021 | 4042 | 0.050 |
Why?
|
| Silver | 1 | 2023 | 122 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2020 | 41006 | 0.050 |
Why?
|
| Databases, Factual | 4 | 2015 | 7729 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2013 | 6196 | 0.050 |
Why?
|
| Genomics | 3 | 2016 | 5720 | 0.050 |
Why?
|
| Informatics | 1 | 2021 | 72 | 0.050 |
Why?
|
| Propensity Score | 2 | 2018 | 1781 | 0.050 |
Why?
|
| Workload | 1 | 2007 | 850 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2018 | 9849 | 0.050 |
Why?
|
| Learning | 1 | 2010 | 1713 | 0.050 |
Why?
|
| International Classification of Diseases | 2 | 2016 | 867 | 0.050 |
Why?
|
| Pathology, Surgical | 2 | 2013 | 155 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1956 | 0.050 |
Why?
|
| Sample Size | 1 | 2023 | 845 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2005 | 1827 | 0.050 |
Why?
|
| Vitamin D | 1 | 2013 | 3223 | 0.040 |
Why?
|
| Self Care | 1 | 2005 | 786 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5751 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 305 | 0.040 |
Why?
|
| Psychiatry | 1 | 2011 | 1695 | 0.040 |
Why?
|
| Data Collection | 1 | 2008 | 3341 | 0.040 |
Why?
|
| Telemedicine | 1 | 2016 | 2872 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7474 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3079 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2003 | 372 | 0.040 |
Why?
|
| Colestipol | 1 | 2018 | 10 | 0.040 |
Why?
|
| Cholestyramine Resin | 1 | 2018 | 24 | 0.040 |
Why?
|
| Fibric Acids | 1 | 2018 | 25 | 0.040 |
Why?
|
| Risk | 2 | 2020 | 9687 | 0.040 |
Why?
|
| Research Design | 2 | 2011 | 5987 | 0.040 |
Why?
|
| Social Environment | 1 | 2023 | 1023 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 354 | 0.040 |
Why?
|
| Italy | 1 | 2019 | 832 | 0.040 |
Why?
|
| Models, Biological | 1 | 2013 | 9583 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77449 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 351 | 0.040 |
Why?
|
| Ferritins | 1 | 2019 | 590 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2373 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 12951 | 0.030 |
Why?
|
| Critical Care | 1 | 2008 | 2647 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6487 | 0.030 |
Why?
|
| Physicians | 1 | 2013 | 4567 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2006 | 8324 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2018 | 572 | 0.030 |
Why?
|
| United States | 5 | 2019 | 69872 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2018 | 594 | 0.030 |
Why?
|
| Comorbidity | 3 | 2016 | 10388 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 514 | 0.030 |
Why?
|
| Prognosis | 4 | 2016 | 29063 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8949 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1999 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 39050 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2018 | 850 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 1401 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1654 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2006 | 3679 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2013 | 613 | 0.030 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 370 | 0.020 |
Why?
|
| Computer Security | 1 | 2013 | 262 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12261 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11524 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15295 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2012 | 270 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 789 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1783 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2019 | 53288 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2012 | 306 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6459 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 288 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2008 | 26 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2010 | 284 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2008 | 44 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 2356 | 0.020 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2008 | 125 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2008 | 107 | 0.020 |
Why?
|
| Software Design | 1 | 2008 | 176 | 0.020 |
Why?
|
| Nursing Process | 1 | 2007 | 16 | 0.020 |
Why?
|
| Nursing Research | 1 | 2008 | 77 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2008 | 160 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2494 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 676 | 0.020 |
Why?
|
| Decision Trees | 1 | 2008 | 506 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2309 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 2593 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1790 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2019 | 2788 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Nursing Informatics | 1 | 2006 | 42 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7785 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4462 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1504 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 1775 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3255 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 2759 | 0.010 |
Why?
|
| Time Factors | 2 | 2018 | 40075 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 35421 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1431 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10397 | 0.010 |
Why?
|
| Internet | 1 | 2010 | 3064 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5078 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23338 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2008 | 2616 | 0.010 |
Why?
|
| Radiology | 1 | 2010 | 2100 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 35136 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 25043 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 85781 | 0.010 |
Why?
|
| Health Status | 1 | 2003 | 4034 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 56430 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2003 | 4371 | 0.000 |
Why?
|